Overview


According to FutureWise analysis the market for HLA Typing in 2023 is US$ 1.49 billion, and is expected to reach US$ 2.51 billion by 2031 at a CAGR of 6.72%.

Increased insistence for diagnostic products, increased private-public collaboration for extensive HLA research, rising prevalence of infectious diseases and soaring number of transplant processes are some of the crucial factors responsible for the growth of the market. HLA class I and II antigen identification is performed by the procedure of molecular diagnostics that is based on DNA. These novel innovations of the DNA are being utilised by the HLA typing that provide more accurate, vigorous results that rely on identifying the differences in HLA genes. Furthermore, advancements in technology, rise in the number of processes that involve stem cell transplantation, soft tissue transplantation and solid organ transplantation, bolstering support in R and D, escalating public and private funds are some of the other driving factors responsible for the HLA typing market growth. Additionally, the technological shift to gene-based HLA profiling from serological assays shall boost the proliferation of the market.

  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • Illumina
  • CareDx Inc.
  • Immucor Inc.
  • Bio-Rad Laboratories Inc.
  • Hoffman-La Roche Ltd.
  • Hologic Inc.
  • Luminex
  • Biofortuna
  • Takara Bio
  • Omixon

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Technology

  •   Molecular Assay Technologies
    •  PCR-Based Molecular Assays
      •   Real-Time PCR
      •   Sequence-Specific Primer PCR
      •   Sequence Specific Oligonucleotide PCR
      •   Other PCR Molecular Assays
    •  Sequencing based Molecular Assays
      •   Sanger Sequencing
      •   Next Generation Sequencing
      •   Other Sequencing Based Molecular Assays
  •   Non-Molecular Assay Technology

By Products and Services

  •   Reagents and Consumables
  •   Instruments
  •   Software and Services

By Application

  •   Diagnostic Applications
    •     Donor-recipient cross-matching
    •     Infectious Disease Testing
    •     Cancer Diagnosis & Prevention
    •     Transfusion Therapy
    •     Other Diagnostic Applications
  •   Research Applications

By End User

  •   Commercial service providers
  •   Hospitals and Surgical Centers
  •   Research Laboratories and Academic Institutes

By Region

  •   North America
  •   Europe
  •   Asia-Pacific
  •   Latin America
  •   Middle East and Africa

The market is fragmented into technology, products and services, application, end user and region. The technology segment is categorised into molecular assay technology and non-molecular assay technology. The molecular assay technology is divided into PCR-based molecular assays and sequencing based molecular assays. The molecular assay technology segment is predicted to hold the largest HLA typing market and this can be credited to the advantages provided by assays like high procedural efficacy, low turnaround time, real-time sample analysis and multi sample studying. The products and service segment is divided into reagents and consumables, instruments, software and services. The application segment is bifurcated into diagnostic applications and research applications. The end user segment is classified into hospitals and transplant centres, research laboratories, academic institutes and independent reference laboratories. The independent reference laboratories dominated the market, and this can be credited to the automation and rapid modernization of diagnostic labs, increased R D activities that are outsourced by biotech and pharmaceutical companies.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the global HLA Typing Market By Technology, By Product and Service, By Application, By End User and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   HLA Typing Market Variables, Trends and Scope

    •     1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of HLA Typing Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   HLA Typing Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   HLA Typing Market, By Technology Historical Analysis and Forecast 2023-2031 (USD million)

    •   1. Molecular Assay Technologies
         1.1. PCR-Based Molecular Assays
          1.1.1. Real-Time PCR
          1.1.2. Sequence-Specific Primer PCR
          1.1.3. Sequence Specific Oligonucleotide PCR
          1.1.4. Other PCR Molecular Assays
         1.2. Sequencing based Molecular Assays
          1.2.1. Sanger Sequencing
          1.2.2. Next Generation Sequencing
          1.2.3. Other Sequencing Based Molecular Assays
        2. Non-Molecular Assay Technology

  • 8.   HLA Typing Market, By Product and Service Historical Analysis and Forecast 2023-2031 (USD million)

    •   1. Reagents and Consumables
        2. Instruments
        3. Software and Services

  • 9.   HLA Typing Market, By Application Historical Analysis and Forecast 2023-2031 (USD million)

    •   1. Diagnostic Applications
         1.1. Donor-recipient cross-matching
         1.2. Infectious Disease Testing
         1.3. Cancer Diagnosis and Prevention
         1.4. Transfusion Therapy
         1.5. Other Diagnostic Applications
        2. Research Applications

  • 10.   HLA Typing HLA Typing Market, By End User Historical Analysis and Forecast 2023-2031 (USD million)

    •   1. Commercial service providers
        2. Hospitals and surgical centers
        3. Research laboratories and academic institutes

  • 11.   North America HLA Typing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America HLA Typing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe HLA Typing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific HLA Typing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa HLA Typing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •          1. Thermo Fisher Scientific Inc.
                   1.1. Company Overview (HQ, Business Segments, Employee Strength)
                   1.2. Product Portfolio
                   1.3. SWOT Analysis
                   1.4. Financial Overview
                   1.5. Strategic Overview
                2. QIAGEN N.V.
                    2.1. Company Overview (HQ, Business Segments, Employee Strength)
                    2.2. Product Portfolio
                    2.3. SWOT Analysis
                    2.4. Financial Overview
                    2.5. Strategic Overview
                3. Illumina
                    3.1. Company Overview (HQ, Business Segments, Employee Strength)
                    3.2. Product Portfolio
                    3.3. SWOT Analysis
                    3.4. Financial Overview
                    3.5. Strategic Overview
                4. CareDx Inc.
                    4.1. Company Overview (HQ, Business Segments, Employee Strength)
                    4.2. Product Portfolio
                    4.3. SWOT Analysis
                    4.4. Financial Overview
                    4.5. Strategic Overview
                5. Immucor Inc.
                    5.1. Company Overview (HQ, Business Segments, Employee Strength)
                    5.2. Product Portfolio
                    5.3. SWOT Analysis
                    5.4. Financial Overview
                    5.5. Strategic Overview
                6. Bio-Rad Laboratories Inc.
                    6.1. Company Overview (HQ, Business Segments, Employee Strength)
                    6.2. Product Portfolio
                    6.3. SWOT Analysis
                    6.4. Financial Overview
                    6.5. Strategic Overview
                7. F. Hoffman-La Roche Ltd.
                   7.1. Company Overview (HQ, Business Segments, Employee Strength)
                   7.2. Product Portfolio
                   7.3. SWOT Analysis
                   7.4. Financial Overview
                   7.5. Strategic Overview
                8. Hologic Inc.
                    8.1. Company Overview (HQ, Business Segments, Employee Strength)
                    8.2. Product Portfolio
                    8.3. SWOT Analysis
                    8.4. Financial Overview
                    8.5. Strategic Overview    
               9. Luminex
                    9.1. Company Overview (HQ, Business Segments, Employee Strength)
                    9.2. Product Portfolio
                    9.3. SWOT Analysis
                    9.4. Financial Overview
                    9.5. Strategic Overview
               10. Biofortuna
                    10.1. Company Overview (HQ, Business Segments, Employee Strength)
                    10.2. Product Portfolio
                    10.3. SWOT Analysis
                    10.4. Financial Overview
                    10.5. Strategic Overview
               11. Takara Bio
                    11.1. Company Overview (HQ, Business Segments, Employee Strength)
                    11.2. Product Portfolio
                    11.3. SWOT Analysis
                    11.4. Financial Overview
                    11.5. Strategic Overview
               12. Omixon
                   12.1. Company Overview (HQ, Business Segments, Employee Strength)
                   12.2. Product Portfolio
                   12.3. SWOT Analysis
                   12.4. Financial Overview
                   12.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact

    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 19.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11